Caliper Technologies, Molecular Devices Settle Patent Suit
The lawsuit alleged that Molecular Devices’ IMAP assay products infringe on two of Caliper's U.S. patents.
As part of the settlement, Caliper and Molecular Devices have entered into a nonexclusive agreement in which Molecular Devices has agreed to pay to Caliper a one-time licensing fee as well as royalties based on future sales of IMAP products.
Financial details of the settlement were not disclosed.
The pair of...
To view the full article, register now.